AI Article Synopsis

  • Antimicrobial resistance in bacteria is increased by the use of antimicrobials in humans, pets, and livestock, which was studied in healthy dogs, cats, sheep, and goats in India to understand E. coli strains' resistance patterns.
  • A high prevalence (76.47%) of ESBL (Extended-Spectrum Beta-Lactamase) producing E. coli was found, with pets showing more significant resistance than livestock, specifically against various antibiotics like tetracycline and azithromycin.
  • Molecular docking demonstrated that certain β-lactamase enzymes had a strong binding affinity for cefotaxime and cefpodoxime, while phylogenetic analysis indicated a link between animal E. coli strains and human clinical strains, raising concerns

Article Abstract

The generation of antimicrobial-resistant bacteria largely depends on the use of antimicrobials not only in humans but also in pet animals and livestock. The present study was conducted to detect the occurrence of beta-lactamase and biofilm-producing- E.coli in healthy pet and backyard livestock. The study also intended on molecular docking experiments to confirm the nature of the catalytic mechanism in β-lactamase enzymes, encoded by the various bla genotypes and phylogenetic analysis to reveal clonal relationship of the animal origin E. coli isolates with human clinical strains. The rectal swabs were collected from healthy dogs (n = 254), cats (n = 108), sheep (n = 119) and goats (n = 143) in India. In total 247 (76.47%) E. coli strains were identified as ESBL producers. The possession of ESBL-producers was significantly more (p < 0.05) in pets than in the backyard livestock. Most of the strains possessed bla like clones. E. coli strains possessing bla, bla, bla and bla like clones, isolated from pets were not reported earlier. The study detected 56.65% of E. coli strains as moderate or strong biofilm producers possessing biofilm-associated genes (csgA, rcsA, rpoS, sdiA). ESBL-producing E. coli showed phenotypical resistance to tetracycline (93.1%), azithromycin (89.8%), ampicillin (84.2%), cefotaxime (80.9%), doxycycline (82.5%), co-trimoxazole (80.9%), ampicillin/cloxacillin (76.9%). The CTX-M variants obtained in this study were modelled by the SWISS-MODEL and verified. Ligand having minimum binding energy, show the highest affinity of β-lactamases for cefotaxime and cefpodoxime. The Gibbs free energy release for all 14 different complex ranges between -6.9 (CTX-M-15.2+cefpodoxime) to -5.3 (CTX-M-218+cefpodoxime) Kcal/mol. Phylogenetic analysis of the animal origin ESBL-E. coli strains revealed a partial clonal relationship with the clinical isolates of local human patients. The present study described the significant presence of biofilm and β-lactamase producing, multi-drug resistant E. coli in pet animals having public health importance.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.micpath.2022.105700DOI Listing

Publication Analysis

Top Keywords

pet animals
8
backyard livestock
8
livestock study
8
docking analysis
4
analysis circulating
4
circulating ctx-m
4
ctx-m variants
4
variants multi-drug
4
multi-drug resistant
4
resistant beta-lactamase
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!